News Industry News Abbott Launches World's First Pivotal Trial To Test New Approach For Repairing Leaky Tricuspid Heart Valves September 05, 2019
News Industry News Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform July 15, 2019
News Industry News Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™ May 06, 2019
News Industry News FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation March 14, 2019
News Industry News CardioMech Appoints Richard Nehm as President and CEO, and Mark Novotny as Chairman November 06, 2018
News Industry News Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc. January 24, 2018
News Industry News Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology September 07, 2017
News Industry News NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR) August 30, 2017
News Industry News 4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum June 16, 2017
News Industry News Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair June 16, 2017
News Industry News LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients May 05, 2017
News Industry News AtriCure Announces the First Patient Enrolled in the FROST Cryoanalgesia Study June 21, 2016
News Industry News Valcare Medical, an Accelmed Portfolio Company, Announces Successful First-In-Human Procedures of the Amend™ Catheter Delivered Annuloplasty Ring June 20, 2016
News Industry News St. Jude Medical Furthers the Company’s Legacy of Heart Valve Excellence With US Launch of the Trifecta Surgical Valve With Glide Technology May 16, 2016
News Industry News NeoChord Receives FDA Approval to begin Clinical Trial for Treatment of Degenerative Mitral Valve Regurgitation May 16, 2016
News Industry News St. Jude Medical Announces the European Launch of the Trifecta Surgical Valve with Glide Technology to Improve Options for Patients in Need of Aortic Valve Replacement April 07, 2016
News Industry News BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device March 07, 2016